Extracellular Purines in Endothelial Cell Barrier Regulation - Extracellular ATP and Adenosine as Regulators of Endothelial Cell Function - page 48

3. Anastasiadis PZ, Reynolds AB. (2000) The p120 catenin family: complex roles in adhesion,
signaling and cancer. J Cell Sci 113 (Pt 8):1319-34.
4. Angiolillo DJ. (2007) ADP receptor antagonism: what's in the pipeline? Am J Cardiovasc
Drugs 7:423-32.
5. Antonov A, Snead C, Gorshkov B, Antonova GN, Verin AD, Catravas JD. (2008) Heat shock
protein 90 inhibitors protect and restore pulmonary endothelial barrier function. Am J Respir
Cell Mol Biol 39:551-9.
6. Beigi R, Kobatake E, Aizawa M, Dubyak GR. (1999) Detection of local ATP release from
activated platelets using cell surface-attached firefly luciferase. Am J Physiol 276:C267-78.
7. Bergfeld GR, Forrester T. (1992) Release of ATP from human erythrocytes in response to a
brief period of hypoxia and hypercapnia. Cardiovasc Res 26:40-7.
8. Birukova AA, Adyshev D, Gorshkov B, Bokoch GM, Birukov KG, Verin AD. (2006)
GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction.
Am J Physiol Lung Cell Mol Physiol 290:L540-8.
9. Birukova AA, Birukov KG, Adyshev D, Usatyuk P, Natarajan V, Garcia JG, Verin AD.
(2005) Involvement of microtubules and Rho pathway in TGF-beta1-induced lung vascular
barrier dysfunction. J Cell Physiol 204:934-47.
10. Birukova AA, Smurova K, Birukov KG, Usatyuk P, Liu F, Kaibuchi K, Ricks-Cord A,
Natarajan V, Alieva I, Garcia JG, Verin AD. (2004) Microtubule disassembly induces
cytoskeletal remodeling and lung vascular barrier dysfunction: role of Rho-dependent
mechanisms. J Cell Physiol 201:55-70.
11. Bodin P, Burnstock G. (1996) ATP-stimulated release of ATP by human endothelial cells.
J Cardiovasc Pharmacol 27:872-5.
12. Bodin P, Burnstock G. (1998) Increased release of ATP from endothelial cells during acute
inflammation. Inflamm Res 47:351-4.
13. Bogatcheva NV, Adyshev D, Mambetsariev B, Moldobaeva N, Verin AD. (2007)
Involvement of microtubules, p38, and Rho kinases pathway in 2-methoxyestradiol-induced
lung vascular barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 292:L487-99.
14. Burnstock G. (2008) Purinergic receptors as future targets for treatment of functional GI
disorders. Gut 57:1193-4.
15. Burnstock G, Williams M. (2000) P2 purinergic receptors: modulation of cell function and
therapeutic potential. J Pharmacol Exp Ther 295:862-9.
16. Carroll JS, Ku CJ, Karunarathne W, Spence DM. (2007) Red blood cell stimulation of
platelet nitric oxide production indicated by quantitative monitoring of the communication
between cells in the bloodstream. Anal Chem 79:5133-8.
17. Chatterjee A, Snead C, Yetik-Anacak G, Antonova G, Zeng J, Catravas JD. (2008) Heat
shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability. Am J
Physiol Lung Cell Mol Physiol 294:L755-63.
18. Chen Y, Harry A, Li J, Smit MJ, Bai X, Magnusson R, Pieroni JP, Weng G, Iyengar R. (1997)
Adenylyl cyclase 6 is selectively regulated by protein kinase A phosphorylation in a region
involved in Galphas stimulation. Proc Natl Acad Sci USA 94:14100-4.
19. Coade SB, Pearson JD. (1989) Metabolism of adenine nucleotides in human blood. Circ Res
65:531-7.
20. Comerford KM, Lawrence DW, Synnestvedt K, Levi BP, Colgan SP. (2002) Role of
vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junctional
permeability. FASEB J 16:583-5.
21. Communi D, Govaerts C, Parmentier M, Boeynaems JM. (1997) Cloning of a human
purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem
272:31969-73.
22. Communi D, Robaye B, Boeynaems JM. (1999) Pharmacological characterization of the
human P2Y11 receptor. Br J Pharmacol 128:1199-206.
23. Coughlin SR. (2000) Thrombin signalling and protease-activated receptors. Nature 407:
258-64.